This is a Study Evaluating the Efficacy and Safety of LTG-001 for Acute Pain After Surgical Removal of Impacted Third Molars
Clinical trial NCT06774625 · COMPLETED
Trial details
- NCT number
- NCT06774625
- Sponsor
- Latigo Biotherapeutics
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-12-19
- Primary completion
- 2025-08-08
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.